Eyebot
Boston
About Eyebot
Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care. It offers a freestanding self-serve vision testing terminal that delivers accurate eye prescriptions directly at the point of sale via an automated experience that allows ophthalmologists to take a proactive approach to eye care. Its 90-second vision test helps patients get the prescriptions they need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: eyebot.co
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Eyewear, Health Diagnostics, Robotics
Social Profiles
Canonical: https://fsome.com/organization/eyebot-102251 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.